These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6356144)

  • 1. Factors affecting immune responsiveness in vitro of germfree allogeneic radiation chimeras. I. Differences between donor and host strains.
    Beardsley TR; Bealmear PM; Mirand EA; Holtermann OA
    Prog Clin Biol Res; 1983; 132C():433-50. PubMed ID: 6356144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mitogen responses of germfree allogeneic chimeras. II. Maturation of two cell types and partial restoration of responsiveness of the short-term chimeras.
    Mattingly JA; Webb PM
    J Immunol; 1978 Apr; 120(4):1274-7. PubMed ID: 25305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.
    Sado T; Kamisaku H; Kubo E
    J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune competence of splenic lymphocytes following graft-vs-host disease in mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1977 Feb; 118(2):657-61. PubMed ID: 14214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alloreactivity and mitogen-induced responses in allogeneic murine bone marrow chimeras].
    Fujimoto H
    Nihon Ketsueki Gakkai Zasshi; 1989 Aug; 52(5):858-68. PubMed ID: 2531528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary and secondary antibody responses to sheep erythrocytes of allogeneic bone marrow chimeras histocompatible at the left or right one-half of the H-2 complex.
    Iwabuchi K; Onoé K; Ogasawara M; Yasumizu R; Morikawa K
    Hokkaido Igaku Zasshi; 1983 May; 58(3):232-7. PubMed ID: 6352445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
    Norin AJ; Emeson EE; Veith FJ
    J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 inhibits severe graft-versus-host disease without mediating the involvement of perforin and granzyme B.
    Tao HR
    Hokkaido Igaku Zasshi; 1998 May; 73(3):227-37. PubMed ID: 9719949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper cell factors restore antibody responses of allogeneic bone marrow chimeras: evidence for ineffective cellular interactions.
    Coico RF; Krown SE; Good RA; Hoffmann MK
    J Immunol; 1982 Apr; 128(4):1590-4. PubMed ID: 6801115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor cells detected in murine bone marrow chimeras.
    Imamura M
    Jpn J Exp Med; 1986 Oct; 56(5):221-8. PubMed ID: 2949096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-associated involution of cellular immune function. I. Accelerated decline of mitogen reactivity of spleen cells in adult thymectomized mice.
    Pachciarz JA; Teague PO
    J Immunol; 1976 Apr; 116(4):982-8. PubMed ID: 1254973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spleen reactivity after BCG treatement: test and strain dependency of the response].
    Florentin I; Orbach-Arbouys S
    Ann Immunol (Paris); 1977; 128(1-2):271-2. PubMed ID: 15497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic radiation chimeras induced in SPF mice: Some immunobiological insights into immunologic dysfunctions and instabilities.
    Sado T; Kamisaku H
    Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):900-8. PubMed ID: 24975
    [No Abstract]   [Full Text] [Related]  

  • 20. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.